These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Blood insulin and diabetes. I. Method of study--normal subjects--diabetic disease]. Duprey J; Lubetzki J Pathol Biol (Paris); 1971 Mar; 19(5):311-31. PubMed ID: 4929994 [No Abstract] [Full Text] [Related]
44. Disproportionately elevated proinsulin levels precede the onset of insulin-dependent diabetes mellitus in siblings with low first phase insulin responses. The Childhood Diabetes in Finland Study Group. Røder ME; Knip M; Hartling SG; Karjalainen J; Akerblom HK; Binder C J Clin Endocrinol Metab; 1994 Dec; 79(6):1570-5. PubMed ID: 7989457 [TBL] [Abstract][Full Text] [Related]
45. Direct measurement of plasma proinsulin in normal and diabetic subjects. Duckworth WC; Kitabchi AE Am J Med; 1972 Oct; 53(4):418-27. PubMed ID: 4672850 [No Abstract] [Full Text] [Related]
46. Insulin, C-peptide, and proinsulin in nondiabetics and insulin-treated diabetics. Characterization of the proinsulin in insulin-treated diabetics. Heding LG Diabetes; 1978; 27 Suppl 1():178-83. PubMed ID: 631439 [No Abstract] [Full Text] [Related]
47. Glucose intolerance in cystic fibrosis. Handwerger S; Roth J; Gorden P; Di Sant' Agnese P; Carpenter DF; Peter G N Engl J Med; 1969 Aug; 281(9):451-61. PubMed ID: 4894429 [No Abstract] [Full Text] [Related]
54. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance. Lanng S; Thorsteinsson B; Røder ME; Orskov C; Holst JJ; Nerup J; Koch C Acta Endocrinol (Copenh); 1993 Mar; 128(3):207-14. PubMed ID: 8480468 [TBL] [Abstract][Full Text] [Related]
55. [Spontaneous hypoglycemia and chronic kidney insufficiency]. Langlois M; Robert G; Nawar T; Caron C Can Med Assoc J; 1978 May; 118(9):1083-6. PubMed ID: 647592 [TBL] [Abstract][Full Text] [Related]
57. Kinetic analysis of the response of plasma glucose, insulin, and C-peptide to glucagon injection in normal and diabetic subjects. Turco G; Brossa C; D'Alberto M; Regis G; Segre G; Bianchi E; Bruni B; Gamba S Diabetes; 1981 Aug; 30(8):685-93. PubMed ID: 7018972 [TBL] [Abstract][Full Text] [Related]
58. [In-vitro changes of the serum binding capacity for 131 I-insulin under tolbutamide and glybenclamide in normal persons, in juvenile and senile diabetes, as well as in insulin resistance]. Schemmel K; Haupt E; Leybold K Klin Wochenschr; 1970 Apr; 48(7):434-5. PubMed ID: 4107054 [No Abstract] [Full Text] [Related]
59. Serum proinsulin in children and adolescents with chemical diabetes. Rosenbloom AL; Starr JI; Juhn D; Rubenstein AH Diabetes; 1975 Aug; 24(8):753-7. PubMed ID: 1158039 [TBL] [Abstract][Full Text] [Related]
60. Proinsulin in pregnant women with normal glucose tolerance or mild gestational diabetes mellitus. Festa A; Shnawa N; Schernthaner G; Haffner SM Exp Clin Endocrinol Diabetes; 1999; 107(7):447-52. PubMed ID: 10595596 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]